Literature DB >> 11557563

Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel.

V P Deenadayalu1, R E White, J N Stallone, X Gao, A J Garcia.   

Abstract

Cardiovascular diseases are often considered to be a predominantly male health problem, and it has been suggested that testosterone exerts deleterious effects on cardiovascular function; however, few experimental studies support this suggestion. Moreover, the cellular and molecular mechanism(s) underlying vascular responses to testosterone is unknown. The present study has investigated the acute effects of testosterone on porcine coronary artery smooth muscle at the tissue and cellular levels. Contractile studies demonstrated that testosterone or dihydrotestosterone (a nonaromatizable metabolite) relaxed these arteries by an endothelium-independent mechanism involving potassium efflux. Direct evidence from patch-clamp studies confirmed that testosterone opened K(+) channels in single coronary myocytes, and further analysis identified this protein as the large-conductance, calcium- and voltage-activated potassium (BK(Ca)) channel. Moreover, inhibiting BK(Ca) channel activity significantly attenuated testosterone-induced coronary relaxation. These findings indicate that testosterone relaxes porcine coronary arteries predominantly by opening BK(Ca) channels in coronary myocytes, and this response may be associated with accumulation of cGMP. This novel mechanism may provide a better understanding of testosterone-induced vasorelaxation reported in recent experimental and early clinical studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557563     DOI: 10.1152/ajpheart.2001.281.4.H1720

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  66 in total

1.  Cardiovascular effects of testosterone: implications of the "male menopause"?

Authors:  K S Channer; T H Jones
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

Review 2.  The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?

Authors:  Richard D Jones; Peter J Pugh; T Hugh Jones; Kevin S Channer
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 3.  Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes.

Authors:  A Mancini; R Festa; V Di Donna; E Leone; G P Littarru; A Silvestrini; E Meucci; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

4.  Bisphenol A activates Maxi-K (K(Ca)1.1) channels in coronary smooth muscle.

Authors:  Shinichi Asano; Johnathan D Tune; Gregory M Dick
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

Review 5.  Gender differences in the cardiovascular effect of sex hormones.

Authors:  Cristiana Vitale; Michael E Mendelsohn; Giuseppe M C Rosano
Journal:  Nat Rev Cardiol       Date:  2009-06-30       Impact factor: 32.419

6.  Crucial role of androgen receptor in vascular H2S biosynthesis induced by testosterone.

Authors:  V Brancaleone; V Vellecco; D S Matassa; R d'Emmanuele di Villa Bianca; R Sorrentino; A Ianaro; M Bucci; F Esposito; G Cirino
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

7.  The vasodilatory effect of testosterone on renal afferent arterioles.

Authors:  Yan Lu; Yiling Fu; Ying Ge; Luis A Juncos; Jane F Reckelhoff; Ruisheng Liu
Journal:  Gend Med       Date:  2012-03-22

8.  Non-genomic effect of testosterone on airway smooth muscle.

Authors:  V Kouloumenta; A Hatziefthimiou; E Paraskeva; K Gourgoulianis; P A Molyvdas
Journal:  Br J Pharmacol       Date:  2006-10-30       Impact factor: 8.739

Review 9.  Testosterone and coronary vascular tone: implications in coronary artery disease.

Authors:  F L Wynne; R A Khalil
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

10.  Testosterone and cholesterol vasodilation of rat aorta involves L-type calcium channel inhibition.

Authors:  E Alvarez; E Cairrão; M Morgado; C Morais; I Verde
Journal:  Adv Pharmacol Sci       Date:  2010-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.